AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 75 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 1.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $79,891 | -91.2% | 11,158 | -90.1% | 0.00% | -100.0% |
| Q4 2021 | $911,000 | +432.7% | 112,797 | +547.9% | 0.00% | – |
| Q3 2021 | $171,000 | +61.3% | 17,410 | +49.0% | 0.00% | – |
| Q1 2021 | $106,000 | +960.0% | 11,688 | +390.7% | 0.00% | – |
| Q3 2018 | $10,000 | -90.7% | 2,382 | -86.5% | 0.00% | – |
| Q2 2018 | $108,000 | -59.7% | 17,607 | -52.1% | 0.00% | – |
| Q1 2018 | $268,000 | – | 36,751 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |